Jeffrey P Bruce

9PUBLICATIONS
106CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer geneticsTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Dec 19, 2025
Investigating Early Kinetics in Plasma ctDNA and Peripheral T-cell Receptor Repertoire to Predict Treatment Outcomes to PD-1 Inhibitors in Head and Neck Squamous Cell Carcinoma.

Enrique Sanz-Garcia, Shirin Soleimani, Jeff P Bruce

|Jan 05, 2024
An Immune Gene Expression Risk Score for Distant Metastases after Radiotherapy for Cervical Cancer.

Jelena Lukovic, Melania Pintilie, Kathy Han

|Jun 16, 2023
Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor Progression.

Stephanie Lheureux, Stephenie D Prokopec, Leslie E Oldfield

|Mar 06, 2023
Repurposing Itraconazole and Hydroxychloroquine to Target Lysosomal Homeostasis in Epithelial Ovarian Cancer.

Stefano Marastoni, Ainhoa Madariaga, Aleksandra Pesic

|Feb 25, 2023
Molecular Genetic Characteristics of FANCI, a Proposed New Ovarian Cancer Predisposing Gene.

Caitlin T Fierheller, Wejdan M Alenezi, Corinne Serruya

|Sep 21, 2022
CD8+ Tumor-Infiltrating Lymphocyte Abundance Is a Positive Prognostic Indicator in Nasopharyngeal Cancer.

Wei Shi, Mackenzie Fijardo, Jeff P Bruce

Pageof 2